Hinova Pharmaceuticals Inc. (SHA:688302)

Hinova Pharmaceuticals Revenue

Hinova Pharmaceuticals had revenue of 26.03M CNY in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 46.50M, up 12,574.70% year-over-year. In the year 2025, Hinova Pharmaceuticals had annual revenue of 20.47M with 5,480.12% growth.

• Revenue (ttm): 46.50M
• Revenue Growth: +12,574.70%
• P/S Ratio: 97.75
• Revenue / Employee: 267.21K
• Employees: 174
• Market Cap: 4.54B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.47M	20.10M	5,480.12%
Dec 31, 2024	366.84K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	1.65M	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error